Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | STAT3 | P40763 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18379120 | 0.83 | STAT3 (0.45) | KDM4EALDH1A1HPGDPOLBKMT2A | |
| SCHEMBL22651728 | 0.82 | KDM4E (0.36) | KDM4EALDH1A1HPGDPOLBALOX15 | |
| SCHEMBL20392828 | 0.80 | STAT3 (0.48) | KDM4EALDH1A1POLBALOX15KMT2A | |
| SCHEMBL22651727 | 0.79 | STAT3 (0.41) | KDM4EALDH1A1POLBALOX15KMT2A | |
| SCHEMBL23987286 | 0.76 | HEXA (0.44) | KDM4EALDH1A1POLBALOX15KMT2A | |
| SCHEMBL22651653 | 0.75 | STAT3 (0.37) | KDM4EALDH1A1HPGDPOLBALOX15 | |
| SCHEMBL22651696 | 0.74 | KDM4E (0.36) | KDM4EALDH1A1POLBALOX15NPC1 | |
| SCHEMBL22651631 | 0.74 | ALDH1A1 (0.41) | KDM4EALDH1A1POLBALOX15KMT2A | |
| SCHEMBL22651619 | 0.74 | ESR1 (0.46) | KDM4EALDH1A1HPGDPOLBALOX15 | |
| SCHEMBL22651617 | 0.74 | ALDH1A1 (0.41) | KDM4EALDH1A1POLBALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354356-A1 | SENSOR COMPOUNDS AND ASSOCIATED METHODS AND DEVICES | UNIVERSITY OF UTAH | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354356-A1 | SENSOR COMPOUNDS AND ASSOCIATED METHODS AND DEVICES | NCS1, DAXX, CNDP2 | KDM4E 4154/4885ALDH1A1 151/4885HPGD 3636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.